The Dow Chemical Company
45
19M
37
0.35
3
0.18
13
- Areas of investment
Summary
The Dow Chemical Company is the famous Corporate Investor, which was founded in 1897. The main department of described Corporate Investor is located in the Midland. The company was established in North America in United States.
The high activity for fund was in 2006. The fund is constantly included in 2-6 deals per year. Speaking about the real fund results, this Corporate Investor is 5 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2014. Comparing to the other companies, this The Dow Chemical Company performs on 1 percentage points less the average number of lead investments.
We also calculated 28 valuable employees in our database.
The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline GreatPoint Energy, Biolex Therapeutics, Fast Track Among the most popular fund investment industries, there are Chemical, Semiconductor.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the The Dow Chemical Company, startups are often financed by Johnson & Johnson Development Corporation, Quaker BioVentures, Prelude Trust. The meaningful sponsors for the fund in investment in the same round are Prelude Trust, ARCH Venture Partners, TTP Ventures. In the next rounds fund is usually obtained by ARCH Venture Partners, 3i Group, Johnson & Johnson Development Corporation.
Investments analytics
Analytics
- Total investments
- 45
- Lead investments
- 3
- Exits
- 13
- Rounds per year
- 0.35
- Follow on index
- 0.18
- Investments by industry
- Health Care (13)
- Biotechnology (12)
- Manufacturing (11)
- Software (7)
- Electronics (6) Show 59 more
- Investments by region
-
- United States (33)
- Switzerland (4)
- United Kingdom (6)
- Kenya (1)
- Germany (1)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 28M
- Group Appearance index
- 0.87
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.92
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Mr. Green Africa | 13 Jan 2022 | Waste Management, Environmental Engineering, Recycling | Early Stage Venture | Nairobi, Nairobi, Kenya | |
| Sparta | 23 Feb 2015 | Software, SaaS, Enterprise Software, Web Browsers | Seed | 118K | Stockholm, Sweden, Stockholm County |
| VeraLight | 03 Jun 2008 | Health Care, Medical, Diabetes | Late Stage Venture | 20M | United States, New Mexico, Albuquerque |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.